Maridea Wealth Management LLC Boosts Stake in HealthEquity, Inc. $HQY

Maridea Wealth Management LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 40.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,272 shares of the company’s stock after buying an additional 8,379 shares during the period. Maridea Wealth Management LLC’s holdings in HealthEquity were worth $2,446,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in HQY. Acumen Wealth Advisors LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at $27,000. Aster Capital Management DIFC Ltd acquired a new stake in HealthEquity during the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd lifted its position in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the period. Torren Management LLC purchased a new stake in HealthEquity during the 4th quarter valued at about $40,000. Finally, Northwestern Mutual Wealth Management Co. grew its stake in HealthEquity by 190.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after purchasing an additional 396 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the sale, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 13,081 shares of company stock worth $1,193,000. 1.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on HQY shares. Barrington Research reissued an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. JPMorgan Chase & Co. reduced their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. Finally, Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.57.

HealthEquity Price Performance

Shares of HQY opened at $88.46 on Friday. The business’s 50-day moving average is $85.30 and its two-hundred day moving average is $84.77. The company has a market capitalization of $7.40 billion, a P/E ratio of 33.13, a P/E/G ratio of 1.40 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $106.60.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.